Arcturus Therapeutics Holdings jobs

Lead Carbon Nanomaterials Engineer Los Angeles | [OnSite]

Lead Process Engineer Los Angeles | [OnSite]

Lead Additive Manufacturing Engineer Los Angeles | [OnSite]

National Clinical Specialist Advanced Therapeutic Remote, UNAVAILABLE, US Position Overview The National Clinical Specialist - Advanced Therapeutics is a national role reporting directly to the Manager, National Clinical Specialist - Advanced Therapeutics within the Sales organization. This position focuses on supporting the Advanced Therapeutics portfolio, with an emphasis on endoscopic retrograde cholangiopancreatography (ERCP), endoscopic ultrasound (EUS), and endobronchial ultrasound (EBUS) technologies. As a support resource, the National Clinical Specialist collaborates with the sales team to drive the achievement of sales goals across Fujifilm's Endoscopy portfolio. This role acts as a subject matter expert, bringing deep clinical and product knowledge in these specialized areas, and works closely with key opinion leaders (KOLs), customers, and internal teams-including sales management, product marketing, and field service engineers-to execute company initiatives. Key responsibilities include supporting clinical product demonstrations, facilitating sales closures, and providing ongoing education and training to company personnel, customers, and sales partners. By combining technical expertise with strategic collaboration, this role ensures exceptional support for the company's Advanced Therapeutics portfolio. Company Overview At FUJIFILM Healthcare Americas Corporation, we're on a mission to innovate for a healthier world, and we need passionate, driven people like you to help us get there. Our cutting-edge healthcare solutions span diagnost

Executive Director, Therapeutic Strategy Leader, APAC Shanghai, China This role is for upcoming future opportunities that may arise at Fortrea. Fortrea is excited to connect with talented individuals for future opportunities. If you meet the job requirements, we'll i...

Associate Director, Pipeline & Portfolio Market Planning Redwood City, California, United States For more than 25 years, Corcept has been singularly focused on the science of cortisol, a powerful hormone that when unregulated, can play a role in a broad range of diseases. Our commercial portfolio includes treatments for hypercortisolism and oncology, and the company has discovered more than 1,000 proprietary selective cortisol modulators and glucocorticoid receptor antagonists. With advanced clinical trials in patients with hypercortisolism, solid tumors, ALS and liver disease, Corcept is unlocking the power of cortisol modulation to help address some of the most devastating diseases patients face today. Corcept is headquartered in Redwood City, California. To learn more, visit www.corcept.com . The Associate Director, Pipeline and Portfolio Market Planning is accountable for developing product strategies across Corcept's oncology portfolio. This individual will guide indication selection and sequencing, competitive landscape assessments, target product profiles (TPPs), product proposition, and long-range financial forecasting to inform program-level decision-making . Responsibilities: - Lead program-level strategy initiatives to define product vision, optimize lifecycle value, and drive business impact - Provide integrated physician, patient, and payer perspective in clinical strategy and new product planning initiatives - Own the design, implementation, and continuous refinement of competitive intelligence and market analysis frameworks that proactively inform program, investment, and governance decisions - Support cross-functional teams, including Commercial, Medical, Development, and Research, to ensure alignment and strategic continuity across the product lifecycle - Develop, maintain, and communicate long-range revenue forecasts and valuation models to support program planning

Vice President, Commercial Manufacturing Operations Remote Vera Therapeutics is a biotechnology company focused on developing treatments for serious immunological diseases. Vera Therapeutics' mission is to advance treatments that target the source of disease in order to change the standard of care for patients. Vera Therapeutics' lead product candidate is atacicept, a fusion protein self-administered at home as a subcutaneous once weekly injection that blocks both B-cell Activating Factor (BAFF) and A Proliferation-Inducing Ligand (APRIL), which stimulate B cells to produce autoantibodies contributing to certain autoimmune diseases, including IgA nephropathy (IgAN) and lupus nephritis. Beyond IgAN, Vera Therapeutics is evaluating additional diseases where the reduction of autoantibodies by atacicept may prove clinically meaningful. In addition, Vera Therapeutics holds an exclusive license agreement with Stanford University for a novel, next generation fusion protein targeting BAFF and APRIL, known as VT-109, with wide therapeutic potential across the spectrum of B-cell-mediated diseases. Vera Therapeutics is also evaluating the development of MAU868, a monoclonal antibody designed to neutralize infection with BK virus, which can have devastating consequences in kidney transplant recipients. Vera Therapeutics retains all global developmental and commercial rights to atacicept, VT-109, and MAU868. For more information, please visit www.veratx.com . Our values are the cornerstone of our culture. Our values inspire us every day and guide everything we do-from how we hire great people, to advancing our mission together, to achieving our ultimate goal to improve medical treatment for patients suffering from immunological diseases. Position Summary: The Vice President, Manufacturing Operations will report

Vice President, Talent Management US Remote “Mineralys Therapeutics is a clinical-stage biopharmaceutical company focused on developing medicines to target hypertension and related comorbidities such as chronic kidney disease (CKD), obstructive sleep apnea (OSA) and other diseases driven by dysregulated aldosterone. Its initial product candidate, lorundrostat, is a proprietary, orally administered, highly selective aldosterone synthase inhibitor. Mineralys is headquartered in Radnor, Pennsylvania. For more information, please visit https://mineralystx.com . Follow Mineralys on LinkedIn, Twitter and Bluesky” Mineralys is a fully remote company. Vice President, Talent Management Position Summary The Vice President, Talent Management is a transformational leader who will design, build and lead a best-in-class, full-lifecycle talent organization at a pivotal moment in our company's history. As we transition from a development-stage company to a commercial enterprise, this leader will serve as the architect of our talent strategy - ensuring we attract, develop, engage and retain the exceptional people needed to bring life-changing therapies to patients. This is a role for a builder - someone who thrives in ambiguity, can construct scalable systems from the ground up and brings the vision, energy and operational excellence to transform talent into a true competitive advantage. The VP, Talent will be a trusted advisor to the organization and a champion of our culture and values across every dimension of the employee experience. Mineralys operates a hub-based remote model, with organizational anchors in Philadelphia, Boston and Boulder. This leader must be equally fluent in building distributed workforce practices and leveraging our hubs as cultural and

Regional Sales Director - Houston US Remote “Mineralys Therapeutics is a clinical-stage biopharmaceutical company focused on developing medicines to target hypertension and related comorbidities such as chronic kidney disease (CKD), obstructive sleep apnea (OSA) and other diseases driven by dysregulated aldosterone. Its initial product candidate, lorundrostat, is a proprietary, orally administered, highly selective aldosterone synthase inhibitor. Mineralys is headquartered in Radnor, Pennsylvania. For more information, please visit https://mineralystx.com . Follow Mineralys on LinkedIn , Twitter and Bluesky ” Mineralys is a fully remote company. Regional Sales Director The Regional Sales Director (RSD) will play a critical role in the successful launch and growth of Mineralys' first commercial product within an assigned region. This leader will be accountable for translating national strategy into regional execution, driving business performance through strong field leadership, cross-functional partnership, and disciplined execution against launch objectives. The RSD will build and lead a high-performing team of territory managers, foster deep customer relationships, and ensure alignment with corporate priorities, compliance standards, and Mineralys' values. This is a highly visible field leadership role requiring strong business acumen, launch experience, and the ability to lead with urgency in a fast-paced, entrepreneurial environment. The RSD will cover a Territory including: - Houston, TX - Shreveport, LA - Jackson, MS Key Responsibilities Commercial Leadership / Launch Execution - Lead all regional launch planning and execution activities to ensure successful market entry and sustained product uptake - Translate national brand strategy into actionable regional business plans and field execution priorities - Lead team

Regional Sales Director - Chicago US Remote “Mineralys Therapeutics is a clinical-stage biopharmaceutical company focused on developing medicines to target hypertension and related comorbidities such as chronic kidney disease (CKD), obstructive sleep apnea (OSA) and other diseases driven by dysregulated aldosterone. Its initial product candidate, lorundrostat, is a proprietary, orally administered, highly selective aldosterone synthase inhibitor. Mineralys is headquartered in Radnor, Pennsylvania. For more information, please visit https://mineralystx.com . Follow Mineralys on LinkedIn , Twitter and Bluesky ” Mineralys is a fully remote company. Regional Sales Director The Regional Sales Director (RSD) will play a critical role in the successful launch and growth of Mineralys' first commercial product within an assigned region. This leader will be accountable for translating national strategy into regional execution, driving business performance through strong field leadership, cross-functional partnership, and disciplined execution against launch objectives. The RSD will build and lead a high-performing team of territory managers, foster deep customer relationships, and ensure alignment with corporate priorities, compliance standards, and Mineralys' values. This is a highly visible field leadership role requiring strong business acumen, launch experience, and the ability to lead with urgency in a fast-paced, entrepreneurial environment. The RSD will cover a Territory including: - Chicago, IL - Naperville, IL - Joliet, IL - Peoria, IL Key Responsibilities Commercial Leadership / Launch Execution - Lead all regional launch planning and execution activities to ensure successful market entry and sustained product uptake - Translate national brand strategy into actionable regional business plans and field execution priorities

Executive Director, Investor Relations Boston, MA The Organization What's happening at Entrada Therapeutics? Entrada is a clinical-stage biopharmaceutical company aiming to transform the lives of patients by establishing a new class of medicines that engage intracellular targets that have long been considered inaccessible. Through proprietary and versatile approaches, Entrada is advancing a robust development portfolio of genetic medicines for the potential treatment of neuromuscular and inherited retinal diseases, among others. Our lead oligonucleotide programs are in development for the potential treatment of people living with Duchenne muscular dystrophy (DMD) who are exon 44, 45, 50 and 51 skipping amenable. Entrada has partnered with Vertex Pharmaceuticals to develop a clinical-stage program, VX-670, for myotonic dystrophy type 1 (DM1). 2026 represents a catalyst-rich period for Entrada. We expect multiple clinical data readouts as we advance several DMD programs across the U.K., EU, and U.S. By year-end 2026, we anticipate four clinical-stage programs in our DMD franchise (ENTR-601-44, ENTR-601-45, ENTR-601-50, and ENTR-601-51). These programs are complemented by the ongoing clinical progress of our DM1 collaboration with Vertex (VX-670). We are a tight-knit team of experts and leaders in both therapeutic development and rare diseases and are excited to grow and attract colleagues who are ready to join a high-energy, dedicated team that likes to get things done and dramatically improve the lives of patients and their families. The Perfect Addition to Our Team You are intellectually curious and can bring new ideas and perspectives to lead the development, implementation, and management of our

Vice President - Pricing & Market Access Watertown, MA Who we are: Kymera is a clinical-stage biotechnology company pioneering the field of targeted protein degradation (TPD) to develop medicines that address critical health problems and have the potential to dramatically improve patients' lives. Kymera is deploying TPD to address disease targets and pathways inaccessible with conventional therapeutics. Having advanced the first degrader into the clinic for immunological diseases, Kymera is focused on building an industry-leading pipeline of oral small molecule degraders to provide a new generation of convenient, highly effective therapies for patients with these conditions. Founded in 2016, Kymera has been recognized as one of Boston's top workplaces for the past several years. For more information about our science, pipeline and people, please visit www.kymeratx.com or follow us on X (formerly Twitter) or LinkedIn . How we work: - PIONEER : We are courageous, resilient and rigorous in our mission to improve patients' lives through our revolutionary degrader medicines. - COLLABORATE : We value trust + transparency from everyone. Our goals are shared, our decisions data-driven and our camaraderie genuine. - BELONG : We recognize our differences, inviting curiosity and inclusivity, so that our people are valued, seen, and heard. How you'll make an impact: The Head of Pricing & Market Access will lead global and U.S. pricing, reimbursement, access, and value strategies across Kymera's pipeline and future commercial products. Reporting to the Chief Commercial Officer, this executive will play a critical role in maximizing patient access and commercial

Director, Insights and Market Development Remote About Apogee Therapeutics Founded in 2022, Apogee Therapeutics, Inc. (Ticker: APGE) is a well-funded, Nasdaq listed company that offers the opportunity to work in a fast-paced, highly dynamic environment. At Apogee, you can actively contribute to shaping the company culture, take on various roles and responsibilities, and grow professionally. Apogee Therapeutics is a clinical-stage biotechnology company advancing novel biologics with potential for differentiated efficacy and dosing in the largest I&I markets, Apogee's antibody programs are designed to overcome limitations of existing therapies by targeting well-established mechanisms of action and incorporating advanced antibody engineering to optimize half-life and other properties. Zumilokibart (APG777), the company's most advanced program, is being initially developed for the treatment of atopic dermatitis (AD), which is the largest and one of the least penetrated I&I markets, as well as asthma. With four validated targets in its portfolio, Apogee is seeking to achieve best-in-class efficacy and dosing through monotherapies and combinations of its novel antibodies. Based on a broad pipeline and depth of leadership and expertise, the company believes it can deliver value and meaningful benefit to patients underserved by today's standard of care. We are a fast-paced company committed to building an exceptional culture, founded on our C.O.R.E. values: C aring, O riginal, R esilient and E goless and a commitment to refusing to stop at “good enough”. If this sounds like you, keep reading! Role Summary We are seeking an experienced Director, Insights and Market Development to serve as a

Associate Director, Clinical Supply Chain Management Remote About Apogee Therapeutics Founded in 2022, Apogee Therapeutics, Inc. (Ticker: APGE) is a well-funded, Nasdaq listed company that offers the opportunity to work in a fast-paced, highly dynamic environment. At Apogee, you can actively contribute to shaping the company culture, take on various roles and responsibilities, and grow professionally. Apogee Therapeutics is a clinical-stage biotechnology company advancing novel biologics with potential for differentiated efficacy and dosing in the largest I&I markets, Apogee's antibody programs are designed to overcome limitations of existing therapies by targeting well-established mechanisms of action and incorporating advanced antibody engineering to optimize half-life and other properties. Zumilokibart (APG777), the company's most advanced program, is being initially developed for the treatment of atopic dermatitis (AD), which is the largest and one of the least penetrated I&I markets, as well as asthma. With four validated targets in its portfolio, Apogee is seeking to achieve best-in-class efficacy and dosing through monotherapies and combinations of its novel antibodies. Based on a broad pipeline and depth of leadership and expertise, the company believes it can deliver value and meaningful benefit to patients underserved by today's standard of care. We are a fast-paced company committed to building an exceptional culture, founded on our C.O.R.E. values: C aring, O riginal, R esilient and E goless and a commitment to refusing to stop at “good enough”. If this sounds like you, keep reading! Role Summary We are seeking a highly motivated and results-oriented individual to join Apogee Therapeutics

Vice President, Pharmaceutical Development Watertown, MA Who we are: Kymera is a clinical-stage biotechnology company pioneering the field of targeted protein degradation (TPD) to develop medicines that address critical health problems and have the potential to dramatically improve patients' lives. Kymera is deploying TPD to address disease targets and pathways inaccessible with conventional therapeutics. Having advanced the first degrader into the clinic for immunological diseases, Kymera is focused on building an industry-leading pipeline of oral small molecule degraders to provide a new generation of convenient, highly effective therapies for patients with these conditions. Founded in 2016, Kymera has been recognized as one of Boston's top workplaces for the past several years. For more information about our science, pipeline and people, please visit www.kymeratx.com or follow us on X (formerly Twitter) or LinkedIn . How we work: - PIONEER : We are courageous, resilient and rigorous in our mission to improve patients' lives through our revolutionary degrader medicines. - COLLABORATE : We value trust + transparency from everyone. Our goals are shared, our decisions data-driven and our camaraderie genuine. - BELONG : We recognize our differences, inviting curiosity and inclusivity, so that our people are valued, seen, and heard. How you'll make an impact: - Define and lead the company's pharmaceutical development strategy across the portfolio, ensuring alignment with corporate priorities and development timelines - Provide strategic leadership for preformulation, biopharmaceutics, and formulation development activities supporting discovery, preclinical, and clinical-stage programs - Champion innovation in formulation sciences and enabling technologies to

Vice President, Senior Counsel – Commercial and Compliance US Remote “Mineralys Therapeutics is a clinical-stage biopharmaceutical company focused on developing medicines to target hypertension and related comorbidities such as chronic kidney disease (CKD), obstructive sleep apnea (OSA) and other diseases driven by dysregulated aldosterone. Its initial product candidate, lorundrostat, is a proprietary, orally administered, highly selective aldosterone synthase inhibitor. Mineralys is headquartered in Radnor, Pennsylvania. For more information, please visit https://mineralystx.com . Follow Mineralys on LinkedIn, Twitter and Bluesky” Mineralys is a fully remote company. Vice President, Senior Counsel - Commercial & Compliance Mineralys is seeking an energetic, versatile, and highly driven attorney to serve as Senior Counsel, Commercial and Compliance. This individual will serve as a strategic legal partner to the Commercial and Medical Affairs teams and will report directly to the Chief Legal Officer. Prior experience assisting with commercial launch is essential. Key Responsibilities Commercial Legal Leadership - Serve as the primary legal advisor to the Commercial and Medical Affairs teams - Provide strategic counsel across pre-launch and launch activities, balancing legal risk with business objectives - Support commercialization readiness, including promotional strategy, market access, patient services, and distribution models - Draft, review, and negotiate a wide range of commercial agreements (e.g., vendors, patient support programs, speaker programs, distribution, market access) - Lead legal review of promotional and medical materials through MLR/PRC processes - Advise on interactions with HCPs, patients, payors, specialty pharmacies, and government entities - Support commercial and medical affairs activities, including speaker programs, advisory boards,

Executive Director / Vice President, Corporate and Internal Communications - BioPharma Remote About Us We are developing potentially best in class therapies for patients living with severe autoimmune diseases. Our lead antibody, claseprubart (DNTH103), is purposefully engineered with extended half-life, improved potency, and high selectivity for only the active C1s complement protein that drives disease pathology - enabling less frequent and more convenient self-administered subcutaneous injections. Our second clinical candidate, DNTH212 is a first and potentially best in class, bifunctional inhibitor that targets clinically validated and complementary disease modifying mechanisms, Type 1 IFN suppression and B cell modulation - enabling potential for improved clinical outcomes and patient friendly convenient, self-administered subcutaneous injections. To learn more, please visit www.dianthustx.com and follow us on LinkedIn . About the Role BioPharma Experience is required. We are seeking a strategic, creative, and execution-oriented ED / VP, Corporate & Internal Communications to build and lead a modern, high-impact communications function in a fast-growing biotech company. This role sits at the intersection of people, corporate brand, and business strategy-responsible for shaping how we communicate internally and externally, strengthening employee engagement, elevating our corporate brand, and ensuring a consistent and compelling company narrative across all audiences, while operating as predominantly a remote company. You will serve as a trusted advisor to senior leadership and partner closely with the VP of Marketing and VP of Investor Relations to ensure alignment across corporate and internal communications. We are building a culture of individuals who hold our core principles at

Senior CRA - Sponsor Dedicated - Italy Milano, Milano, Italy Join Fortrea as a Senior Clinical Research Associate and be part of a global team driving breakthrough clinical trials across key therapeutic areas such as Oncology, Ophthalmology, and Gene Therapy...

Statistical Scientist Shanghai, Shanghai, China's Mainland Contribute technical, therapeutic and business expertise within and external to DSS and PDD, which may include: Research and Development products; Drug development and clinical trial products; Current...

Senior Medical Director Clinical Development Neuroscience Remote, Hybrid, New Haven - CT Arvinas is a clinical-stage biotechnology company dedicated to improving the lives of patients suffering from debilitating and life-threatening diseases through the discovery, development, and commercialization of therapies that degrade disease-causing proteins. Arvinas uses its proprietary PROTAC® Discovery Engine platform to engineer proteolysis targeting chimeras, or PROTAC® targeted protein degraders, that are designed to harness the body's own natural protein disposal system to selectively and efficiently degrade and remove disease-causing proteins. Arvinas is currently progressing multiple investigational drugs through clinical development programs, including ARV-102, targeting LRRK2 for neurodegenerative diseases; ARV-806, targeting KRAS G12D for mutated cancers, including pancreatic, colorectal, and non-small cell lung cancers; ARV-393, targeting BCL6 for relapsed/refractory non-Hodgkin Lymphoma; ARV-027, targeting the polyglutamine-expanded androgen receptor, or polyQ-AR, in skeletal muscle; and vepdegestrant, targeting the estrogen receptor for patients with locally advanced or metastatic ER+/HER2- breast cancer. On August 8 th 2025, the U.S. Food and Drug Administration (FDA) accepted the New Drug Application (NDA) for vepdegestrant- an investigational, orally bioavailable PROTAC estrogen receptor degrader- for its use as a monotherapy in the treatment of adults with estrogen receptor-positive (ER+), human epidermal growth factor receptor 2-negative (HER2-), ESR1-mutated advanced or metastatic breast cancer previously treated with endocrine-based therapy. In September 2025, Arvinas and Pfizer announced their plan to jointly select a third party for the out-licensing and commercialization of vepdegestrant. In April 2024, Arvinas entered into a transaction with Novartis, including a global license agreement for the development

治疗领域经理 - 免疫治疗领域 Beijing, Beijing, China's Mainland Join our team as a Therapeutic Area Manager in Immunotherapy at Roche, where you will manage internal and external resources, deliver scientific product information, and enhance patient benefits through effective communication and collaboration.

治疗领域经理 - 肺癌治疗领域 Tianjin, Tianjin, China's Mainland Join our team as a Therapeutic Area Manager for Lung Cancer, where you will manage internal and external resources, deliver critical product information, and enhance patient outcomes through effective communication and collaboration with healthcare professionals.

治疗领域经理-眼科治疗领域 Shanghai, Shanghai, China's Mainland Join our team as a Therapeutic Area Manager in Ophthalmology, where you will drive academic promotion plans and enhance communication with key healthcare professionals. If you have a strong background in medical knowledge and cross-functional experience, we want to hear from you!

治疗领域经理 - 眼科治疗领域 - 北京 Beijing, Beijing, China's Mainland We are looking for a Therapeutic Area Manager specializing in Ophthalmology to drive scientific communication and enhance patient diagnosis rates. Join Roche to collaborate with clinical experts and coordinate academic meetings, ensuring the delivery of impactful healthcare solutions.